Silo Pharma Inc (SILO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Sales | 18 | 18 | 18 | 18 | 18 |
| Cost of Goods | 2 | 2 | 2 | 2 | 2 |
| Gross Profit | 17 | 17 | 17 | 17 | 17 |
| Operating Expenses | 512 | 545 | 960 | 482 | 455 |
| Operating Income | -494 | -527 | -942 | -464 | -437 |
| Other Income | -164 | -76 | -115 | 6,956 | 48 |
| Pre-tax Income | -658 | -603 | -1,057 | 6,492 | -389 |
| Income Tax | N/A | N/A | 6 | 19 | N/A |
| Net Income Continuous | -658 | -603 | -1,063 | 6,472 | -389 |
| Net Income Discontinuous | N/A | -1 | -26 | -87 | -73 |
| Net Income | $-658 | $-604 | $-1,089 | $6,385 | $-462 |
| EPS Basic Total Ops | -0.33 | -0.31 | -1.85 | 3.20 | 0.00 |
| EPS Basic Continuous Ops | -0.33 | -0.31 | -1.76 | 3.24 | 0.00 |
| EPS Basic Discontinuous Ops | 0.00 | 0.00 | -0.09 | -0.04 | 0.00 |
| EPS Diluted Total Ops | -0.33 | -0.31 | -1.81 | 3.16 | 0.00 |
| EPS Diluted Continuous Ops | -0.33 | -0.31 | -1.74 | 3.20 | 0.00 |
| EPS Diluted Discontinuous Ops | 0.00 | 0.00 | -0.09 | -0.04 | 0.00 |
| EBITDA(a) | $-494 | $-527 | $-942 | $-464 | $-430 |